Sari Karlsson

Summary

Affiliation: Tampere University Hospital
Country: Finland

Publications

  1. pmc Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for
    Anders Perner
    Department of Intensive Care, Centre of Clinical Intervention Research, Copenhagen University Hospital, Rigshospitalet, Denmark
    Trials 12:24. 2011
  2. pmc One-year mortality, quality of life and predicted life-time cost-utility in critically ill patients with acute respiratory failure
    Rita Linko
    Department of Anaesthesia and Intensive Care Medicine, Helsinki University Hospital, Sairaalakatu 1, Helsinki, Finland
    Crit Care 14:R60. 2010
  3. doi Vascular endothelial growth factor in severe sepsis and septic shock
    Sari Karlsson
    Department of Intensive Care Medicine, Tampere University Hospital, Finland
    Anesth Analg 106:1820-6. 2008
  4. ncbi Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study
    Sari Karlsson
    Aurinkokatu 3B38, 13100, Hameenlinna, Finland
    Intensive Care Med 33:435-43. 2007
  5. doi HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis
    Sari Karlsson
    Department of Intensive Care Medicine, Tampere University Hospital, Teiskontie 35, Tampere, Finland
    Intensive Care Med 34:1046-53. 2008
  6. pmc Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study
    Sari Karlsson
    Department of Intensive Care Medicine, Tampere University Hospital, Teiskontie 35, 33521 Tampere, Finland
    Crit Care 14:R205. 2010
  7. doi Long-term outcome and quality-adjusted life years after severe sepsis
    Sari Karlsson
    Department of Intensive Care Medicine, Tampere University Hospital, Tampere, Finland
    Crit Care Med 37:1268-74. 2009
  8. pmc A multibiomarker-based outcome risk stratification model for adult septic shock*
    Hector R Wong
    1Division of Critical Care Medicine, Cincinnati Children s Hospital Medical Center and Cincinnati Children s Hospital Research Foundation, Cincinnati, OH 2Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 3Department of Emergency Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 4Intensive Care Units, Division of Anaesthesia and Intensive Care Medicine, Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland 5Pulmonary, Allergy, and Critical Care Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 6University of British Columbia, Vancouver, BC, Canada 7Critical Care Research Laboratories, Centre for Heart Lung Innovation, St Paul s Hospital, Vancouver, BC, Canada 8Department of Intensive Care Medicine, Tampere University Hospital, Tampere, Finland 9Department of Intensive Care Medicine, Kuopio University Hospital, Kuopio, Finland 10Department of Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA
    Crit Care Med 42:781-9. 2014
  9. doi Prognostic Value of Secretoneurin in Critically Ill Patients With Infections
    Helge Røsjø
    1Division of Medicine, Akershus University Hospital, Lørenskog, NORWAY 2Center for Heart Failure Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway 3Department of Medical Sciences, Uppsala University, Uppsala, Sweden 4Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway 5Bioinformatics core facility, University of Oslo and Oslo University Hospital, Oslo, Norway 6Department of Intensive Care Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland 7Department of Intensive Care Medicine, Bern University Hospital, University of Bern, Bern, Switzerland 8Department of Intensive Care Medicine, Tampere University Hospital, Tampere, Finland 9Intensive Care Medicine, Kuopio University Hospital, Kuopio, Finland
    Crit Care Med 44:1882-90. 2016
  10. doi Free cortisol in sepsis and septic shock
    Stepani Bendel
    Department of Intensive Care, Kuopio University Hospital, PL 16222 Kuopio, Finland
    Anesth Analg 106:1813-9. 2008

Collaborators

  • E Ruokonen
  • Ville Pettila
  • Rita Linko
  • Jyrki Tenhunen
  • Ilkka Parviainen
  • Marjut Varpula
  • Marja S Hynninen
  • Torbjørn Omland
  • Helge Røsjø
  • James A Russell
  • Jason D Christie
  • Nuala J Meyer
  • John H Boyd
  • Keith R Walley
  • Tero Ala-Kokko
  • Pekka Loisa
  • K A Saukkonen
  • Hector R Wong
  • Anders Perner
  • Stepani Bendel
  • Michael G S Shashaty
  • Simone A Thair
  • Kimberly W Hart
  • Christopher D Fjell
  • Patrick Lahni
  • Christopher J Lindsell
  • Nicolai Haase
  • Claude Kancir
  • Peter Søe-Jensen
  • Nils H Larsen
  • Pål Klepstad
  • Hans Henrik Bulow
  • Anne Lene Kjældgaard
  • Jørgen Wiis
  • Maija Kaukonen
  • Jan Wernerman
  • Frank Pott
  • Jørn Wetterslev
  • Bjarne Fogh
  • Pawel Berezowicz
  • Juha Rutanen
  • Kristian R Madsen
  • Lars Broksø Holst
  • Per Martin Bådstøløkken
  • Morten Steensen
  • Morten Bestle
  • Sigurbergur Karason
  • Hamid Tousi
  • Ole Schøidt
  • Anne Berit Guttormsen
  • Anders Aneman
  • Marcela Carlsson
  • Gudmundur Klemenzson
  • Robert Winding
  • Jonas Nielsen
  • Karen Doris Bødker
  • Siv Leivdal
  • John Asger Petersen
  • Malgorzata Pawlowicz
  • Susanne Iversen
  • Asger Bendtsen
  • Jussi Pentti
  • Raili Laru Sompa
  • Ari Alaspää
  • Jouko Laurila
  • Outi Kiviniemi
  • Tero Varpula
  • Seija Alila
  • Markku Suvela
  • Seppo Hovilehto
  • Pentti Kairi
  • Jorma Heikkinen
  • Tuula Korhonen
  • Tadeusz Kaminski
  • Heikki Laine
  • Vesa Lund
  • Tero Ala Kokko
  • Pertti Arvola
  • Kari Saarinen

Detail Information

Publications13

  1. pmc Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for
    Anders Perner
    Department of Intensive Care, Centre of Clinical Intervention Research, Copenhagen University Hospital, Rigshospitalet, Denmark
    Trials 12:24. 2011
    ..Now lower molecular weight HES 130/0.4 is the preferred colloid in Scandinavian intensive care units (ICUs) and 1st choice fluid for patients with severe sepsis. However, HES 130/0.4 is largely unstudied in patients with severe sepsis...
  2. pmc One-year mortality, quality of life and predicted life-time cost-utility in critically ill patients with acute respiratory failure
    Rita Linko
    Department of Anaesthesia and Intensive Care Medicine, Helsinki University Hospital, Sairaalakatu 1, Helsinki, Finland
    Crit Care 14:R60. 2010
    ....
  3. doi Vascular endothelial growth factor in severe sepsis and septic shock
    Sari Karlsson
    Department of Intensive Care Medicine, Tampere University Hospital, Finland
    Anesth Analg 106:1820-6. 2008
    ..Vascular endothelial growth factor (VEGF) levels have been shown to be elevated in severe sepsis. We investigated the value of VEGF in predicting organ dysfunction and hospital mortality in adult patients with severe sepsis...
  4. ncbi Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study
    Sari Karlsson
    Aurinkokatu 3B38, 13100, Hameenlinna, Finland
    Intensive Care Med 33:435-43. 2007
    ..To determine the incidence and outcome of severe sepsis in the adult Finnish population and to evaluate how treatment guidelines in severe sepsis are applied in clinical practice...
  5. doi HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis
    Sari Karlsson
    Department of Intensive Care Medicine, Tampere University Hospital, Teiskontie 35, Tampere, Finland
    Intensive Care Med 34:1046-53. 2008
    ..To study the predictive value of high mobility group box-1 protein (HMGB1) and hospital mortality in adult patients with severe sepsis...
  6. pmc Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study
    Sari Karlsson
    Department of Intensive Care Medicine, Tampere University Hospital, Teiskontie 35, 33521 Tampere, Finland
    Crit Care 14:R205. 2010
    ..This prospective study investigated the predictive value of procalcitonin (PCT) for survival in 242 adult patients with severe sepsis and septic shock treated in intensive care...
  7. doi Long-term outcome and quality-adjusted life years after severe sepsis
    Sari Karlsson
    Department of Intensive Care Medicine, Tampere University Hospital, Tampere, Finland
    Crit Care Med 37:1268-74. 2009
    ..To study long-term mortality, quality of life (QOL), quality-adjusted life years (QALYs), and costs per QALY in an unselected intensive care unit (ICU) patient population with severe sepsis...
  8. pmc A multibiomarker-based outcome risk stratification model for adult septic shock*
    Hector R Wong
    1Division of Critical Care Medicine, Cincinnati Children s Hospital Medical Center and Cincinnati Children s Hospital Research Foundation, Cincinnati, OH 2Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 3Department of Emergency Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 4Intensive Care Units, Division of Anaesthesia and Intensive Care Medicine, Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland 5Pulmonary, Allergy, and Critical Care Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 6University of British Columbia, Vancouver, BC, Canada 7Critical Care Research Laboratories, Centre for Heart Lung Innovation, St Paul s Hospital, Vancouver, BC, Canada 8Department of Intensive Care Medicine, Tampere University Hospital, Tampere, Finland 9Department of Intensive Care Medicine, Kuopio University Hospital, Kuopio, Finland 10Department of Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA
    Crit Care Med 42:781-9. 2014
    ..Investigators advocate that interventional trials in septic shock require effective outcome risk stratification. We derived and tested a multibiomarker-based approach to estimate mortality risk in adults with septic shock...
  9. doi Prognostic Value of Secretoneurin in Critically Ill Patients With Infections
    Helge Røsjø
    1Division of Medicine, Akershus University Hospital, Lørenskog, NORWAY 2Center for Heart Failure Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway 3Department of Medical Sciences, Uppsala University, Uppsala, Sweden 4Institute for Experimental Medical Research, Oslo University Hospital, Oslo, Norway 5Bioinformatics core facility, University of Oslo and Oslo University Hospital, Oslo, Norway 6Department of Intensive Care Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland 7Department of Intensive Care Medicine, Bern University Hospital, University of Bern, Bern, Switzerland 8Department of Intensive Care Medicine, Tampere University Hospital, Tampere, Finland 9Intensive Care Medicine, Kuopio University Hospital, Kuopio, Finland
    Crit Care Med 44:1882-90. 2016
    ..As myocardial dysfunction contributes to poor outcome in critically ill patients, we wanted to assess the prognostic value of secretoneurin in two cohorts of critically ill patients with infections...
  10. doi Free cortisol in sepsis and septic shock
    Stepani Bendel
    Department of Intensive Care, Kuopio University Hospital, PL 16222 Kuopio, Finland
    Anesth Analg 106:1813-9. 2008
    ..We measured total and free cortisol in patients with severe sepsis and related the concentrations to outcome...
  11. doi Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock
    Katri Saukkonen
    Departments of Medicine and Emergency Care, Helsinki University Central Hospital, Helsinki, Finland
    Clin Chem 54:1000-7. 2008
    ..We investigated the value of plasma DNA for the prediction of intensive care unit (ICU) and hospital mortality and its association with the degree of organ dysfunction and disease severity in patients with severe sepsis...
  12. ncbi Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock
    Marjut Varpula
    Department of Surgery, Helsinki University Hospital, Finland
    Crit Care Med 35:1277-83. 2007
    ..The aim of this study was to evaluate the predictive value of N-terminal pro-brain natriuretic peptide (NT-proBNP) on mortality in a large, unselected patient population with severe sepsis and septic shock...
  13. ncbi Mixed venous oxygen saturation cannot be estimated by central venous oxygen saturation in septic shock
    Marjut Varpula
    Helsinki University Hospital, POB 340, 00029 HUS, Helsinki, Finland
    Intensive Care Med 32:1336-43. 2006
    ..The aim of our study was to assess the correlation and agreement of ScvO2 and SvO2 and compare ScvO2-SvO2 difference to lactate, oxygen-derived and hemodynamic parameters in early septic shock in ICU after initial resuscitation...